The Nasdaq (NDAQ) Stock Market announced that trading is halted in Charming Medical (MCTA) for additional information requested from the company. Previously, the Securities and Exchange Commission effected a trading suspension in MCTA from 04:00:00 on November 12, 2025 to 23:59:00 on November 25, 2025. The last sale price of the company’s ordinary shares was $29.355.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NDAQ:
- Nasdaq expands partnership with Revolut
- Polymarket Returns to U.S. as Popularity of Prediction Markets Grows
- Nasdaq, IonQ, Opko, Exact, Palo Alto: Trending by Analysts
- Swiss Bank UBS (UBS) Says Silver Is Likely to Outperform Gold in 2026
- Midday Fly By: Nvidia reports Q3 beat, Abbott buys Exact Sciences